The medical aesthetics segment is evolving rapidly, driven by changing patient expectations, technological innovation, and increasing demand for minimally invasive procedures. Patients are seeking personalized, safe, and clinically effective treatments, including injectables (e.g., hyaluronic acid fillers), energy-based devices, and skin treatments. Strong growth in these categories reflects rising interest in visible, science-backed outcomes with limited downtime. Digital channels and social media play a key role in shaping patient awareness, clinic selection, and treatment decisions, requiring companies to adapt their engagement and education strategies. Regulatory frameworks vary significantly across geographies, impacting product approvals, clinical use, and treatment delivery standards. At the same time, innovation cycles are accelerating, increasing the need for continuous product development, differentiated clinical positioning, and practitioner training. Supply chain reliability, manufacturing scalability, and cost control remain critical to support growth and maintain profitability in an increasingly competitive environment.

We support medical aesthetics companies across all dimensions of strategic and operational execution. 

  • Corporate Strategy: we help define global ambitions, assess market opportunities, optimize portfolios, design business models, and develop 3- to 5-year growth plans, including partnerships, alliances, and market entry strategies
  • Customer Insights: we map consumers, aesthetic physicians and surgeons, capture the voice of the customer, and refine value propositions to enhance differentiation and engagement
  • Commercial Strategy: we design go-to-market models, launch readiness plans, commercial excellence programs, pricing and promotional strategies, competitive benchmarking, and strategic differentiation initiatives
  • Medical Affairs: we advise on evidence generation and scientific communications where relevant to support brand credibility
  • R&D and Innovation: we optimize innovation sourcing, portfolio prioritization, lifecycle management, and development processes to accelerate product introductions
  • M&A and Transactions: we conduct commercial and vendor due diligence, build-up strategies, acquisitions, and post-merger integration to expand product portfolios and geographic reach

By combining deep consumer health expertise with end-to-end strategic and operational support, we help medical aesthetics companies accelerate growth, optimize portfolios, navigate regulatory and geopolitical complexity, enhance consumer trust, and deliver sustainable value across physical and digital channels.